Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
Huang JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051377 · marketforms-66260.xml · derivative · entry 1 Huang Jane · CIK 0001683913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051378 · marketforms-66261.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
GARCEAU ROGERDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051376 · marketforms-66259.xml · derivative · entry 1 GARCEAU ROGER · CIK 0001451767 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
SARGEN GREGORYDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051379 · marketforms-66262.xml · derivative · entry 1 SARGEN GREGORY · CIK 0001227835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
BESHAR LUKE MDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051375 · marketforms-66258.xml · derivative · entry 1 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
Flannelly Barry PDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051382 · marketforms-66265.xml · derivative · entry 1 Flannelly Barry P · CIK 0001615842 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 22:00 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.67 | $0.00 |
DisclosureSEC source: 0001213900-24-051381 · marketforms-66263.xml · derivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| May 31, 2024 Filed May 31, 2024 20:05 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 5,824 | $2.90 | $16,894.84 |
DisclosureSEC source: 0001493152-24-022195 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 108,696 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.9007-$2.9011 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 30, 2024 Filed May 31, 2024 20:05 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 9,230 | $2.94 | $27,113.13 |
DisclosureSEC source: 0001493152-24-022195 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 114,520 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.90-$2.98 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 22, 2024 Filed May 23, 2024 23:01 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 500 | $3.00 | $1,501.05 |
DisclosureSEC source: 0001493152-24-021230 · ownership.xml · nonDerivative · entry 4 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 123,750 F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.03 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 22, 2024 Filed May 23, 2024 23:01 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 9,300 | $3.02 | $28,095.30 |
DisclosureSEC source: 0001493152-24-021230 · ownership.xml · nonDerivative · entry 3 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 2,272,859 F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.03 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:01 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 1,800 | $3.06 | $5,500.26 |
DisclosureSEC source: 0001493152-24-021230 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 124,250 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01-$3.17 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:01 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 31,200 | $3.06 | $95,337.84 |
DisclosureSEC source: 0001493152-24-021230 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 2,282,159 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01-$3.17 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| May 17, 2024 Filed May 17, 2024 23:48 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 1,200 | $3.06 | $3,672.72 |
DisclosureSEC source: 0001493152-24-020507 · ownership.xml · nonDerivative · entry 4 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 126,050 F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.10 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 17, 2024 Filed May 17, 2024 23:48 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 2,750 | $3.33 | $9,152.28 |
DisclosureSEC source: 0001493152-24-020507 · ownership.xml · nonDerivative · entry 3 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed account Disclosed balance after: 127,250 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01-$3.60 inclusive. The reporting person undertakes to provide,upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| May 17, 2024 Filed May 17, 2024 23:48 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 19,685 | $3.06 | $60,247.91 |
DisclosureSEC source: 0001493152-24-020507 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 2,313,359 F4 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.10 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| May 17, 2024 Filed May 17, 2024 23:48 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 47,250 | $3.33 | $157,252.73 |
DisclosureSEC source: 0001493152-24-020507 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 2,333,044 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.01-$3.60 inclusive. The reporting person undertakes to provide,upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| May 10, 2024 Filed May 10, 2024 22:57 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 151,700 | $3.11 | $472,424.14 |
DisclosureSEC source: 0001493152-24-018723 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 2,380,294 F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.00-$3.20 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| May 09, 2024 Filed May 10, 2024 22:57 UTC |
Opaleye Management Inc.10% owner
|
SaleCommon Stock, par value $0.001 per share | 30,600 | $3.09 | $94,526.46 |
DisclosureSEC source: 0001493152-24-018723 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 2,531,994 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.05-$3.15 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F1 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Zummo JacquelineChf Scientific Operations Off
|
GrantStock Option (Right to Buy) · Derivative | 137,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005724 · marketforms-64336.xml · derivative · entry 3 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,000 Underlying: Common Stock · 137,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Zummo JacquelineChf Scientific Operations Off
|
Tax withholdingCommon Stock | 3,049 | $1.91 | $5,823.59 |
DisclosureSEC source: 0001213900-24-005724 · marketforms-64336.xml · nonDerivative · entry 2 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,296 F3 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Zummo JacquelineChf Scientific Operations Off
|
GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005724 · marketforms-64336.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,345 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Fabbio PatrickChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 131,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005723 · marketforms-64339.xml · derivative · entry 2 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,000 Underlying: Common Stock · 131,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Fabbio PatrickChief Financial Officer
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005723 · marketforms-64339.xml · nonDerivative · entry 1 Fabbio Patrick · CIK 0001658859 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Shefferman JesseDirector · CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 357,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005725 · marketforms-64334.xml · derivative · entry 3 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,000 Underlying: Common Stock · 357,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Shefferman JesseDirector · CEO and President
|
Tax withholdingCommon Stock | 7,803 | $1.91 | $14,903.73 |
DisclosureSEC source: 0001213900-24-005725 · marketforms-64334.xml · nonDerivative · entry 2 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 944,064 F3 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Shefferman JesseDirector · CEO and President
|
GrantCommon Stock | 59,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005725 · marketforms-64334.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 951,867 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Bandari JathinChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 137,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005726 · marketforms-64335.xml · derivative · entry 3 Bandari Jathin · CIK 0001903622 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,000 Underlying: Common Stock · 137,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Bandari JathinChief Medical Officer
|
Tax withholdingCommon Stock | 2,879 | $1.91 | $5,498.89 |
DisclosureSEC source: 0001213900-24-005726 · marketforms-64335.xml · nonDerivative · entry 2 Bandari Jathin · CIK 0001903622 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,704 F3 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Bandari JathinChief Medical Officer
|
GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005726 · marketforms-64335.xml · nonDerivative · entry 1 Bandari Jathin · CIK 0001903622 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,583 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Fry HannahVP, Controller
|
GrantStock Option (Right to Buy) · Derivative | 46,000 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · derivative · entry 3 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,000 Underlying: Common Stock · 46,000 shares Expires 2034-01-18 F2 · derivative.exercise_date: 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Fry HannahVP, Controller
|
Tax withholdingCommon Stock | 904 | $1.91 | $1,726.64 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · nonDerivative · entry 2 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,836 F3 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 21:05 UTC |
Fry HannahVP, Controller
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-005722 · marketforms-64340.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,740 F1 · shares: The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 21:05 UTC |
Zummo JacquelineChf Scientific Operations Off
|
Tax withholdingCommon Stock | 5,229 | $2.39 | $12,497.31 |
DisclosureSEC source: 0001213900-24-003335 · marketforms-64051.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,345 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 21:05 UTC |
Shefferman JesseDirector · CEO and President
|
Tax withholdingCommon Stock | 5,746 | $2.39 | $13,732.94 |
DisclosureSEC source: 0001213900-24-003336 · marketforms-64052.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 892,867 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 21:05 UTC |
Bandari JathinChief Medical Officer
|
Tax withholdingCommon Stock | 1,877 | $2.39 | $4,486.03 |
DisclosureSEC source: 0001213900-24-003334 · marketforms-64050.xml · nonDerivative · entry 1 Bandari Jathin · CIK 0001903622 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,583 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2022. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:35 UTC |
Zummo JacquelineChf Scientific Operations Off
|
Tax withholdingCommon Stock | 1,899 | $2.17 | $4,120.83 |
DisclosureSEC source: 0001213900-24-001546 · marketforms-63997.xml · nonDerivative · entry 1 Zummo Jacqueline · CIK 0001798929 · Chf Scientific Operations Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,574 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:30 UTC |
Shefferman JesseDirector · CEO and President
|
Tax withholdingCommon Stock | 5,840 | $2.17 | $12,672.80 |
DisclosureSEC source: 0001213900-24-001541 · marketforms-63998.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 898,613 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:05 UTC |
Fry HannahVP, Controller
|
Tax withholdingCommon Stock | 324 | $2.17 | $703.08 |
DisclosureSEC source: 0001213900-24-001512 · marketforms-63995.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,740 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 20:05 UTC |
Fry HannahVP, Controller
|
Tax withholdingCommon Stock | 10,075 | $2.56 | $25,792.00 |
DisclosureSEC source: 0001213900-23-057844 · marketforms-62056.xml · nonDerivative · entry 1 Fry Hannah · CIK 0001938146 · VP, Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,064 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 16, 2022. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 20:05 UTC |
Bandari JathinChief Medical Officer
|
Tax withholdingCommon Stock | 682 | $2.46 | $1,677.72 |
DisclosureSEC source: 0001213900-23-054759 · marketforms-61989.xml · nonDerivative · entry 1 Bandari Jathin · CIK 0001903622 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,460 F1 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020. Read SEC document |
| June 27, 2023 Filed Jun 27, 2023 23:26 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 7,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-052231 · ownership.xml · nonDerivative · entry 2 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 904,453 Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 23:26 UTC |
Shefferman JesseDirector · CEO and President
|
GiftCommon Stock | 1,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-052231 · ownership.xml · nonDerivative · entry 1 Shefferman Jesse · CIK 0001799167 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 911,873 Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
Solomon Michael EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047468 · ownership.xml · derivative · entry 1 Solomon Michael Edward · CIK 0001799320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
Huang JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047466 · ownership.xml · derivative · entry 1 Huang Jane · CIK 0001683913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
Levy Richard SDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047467 · ownership.xml · derivative · entry 1 Levy Richard S · CIK 0001454983 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
GARCEAU ROGERDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047472 · ownership.xml · derivative · entry 1 GARCEAU ROGER · CIK 0001451767 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
SARGEN GREGORYDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047469 · ownership.xml · derivative · entry 1 SARGEN GREGORY · CIK 0001227835 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
BESHAR LUKE MDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047470 · ownership.xml · derivative · entry 1 BESHAR LUKE M · CIK 0001192128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:10 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001213900-23-047471 · ownership.xml · derivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.